Collegium Pharmaceutical (COLL) Long-Term Deferred Tax (2014 - 2026)
Collegium Pharmaceutical (COLL) posted quarterly Long-Term Deferred Tax of $113.6 million for Q1 2026, up 23.89% year-over-year from $91.7 million in Q1 2025, and up 0.91% quarter-over-quarter from $112.5 million in Q4 2025.
Collegium Pharmaceutical (COLL) Long-Term Deferred Tax (2014 - 2026) Analysis & Trends
Collegium Pharmaceutical's Long-Term Deferred Tax history runs 8 years deep, the most recent figure standing at $113.6 million for Q1 2026.
- In Q1 2026, Long-Term Deferred Tax rose 23.89% year-over-year to $113.6 million; the TTM figure through Mar 2026 stood at $113.6 million (up 23.89% YoY), while the FY2025 annual figure was $112.5 million, up 14.8% from the prior year.
- Long-Term Deferred Tax for Q1 2026 stood at $113.6 million, up from $112.5 million in the prior quarter.
- The five-year high for Long-Term Deferred Tax was $113.6 million in Q1 2026, with the low at $24.0 million in Q4 2022.
- The 5-year median for Long-Term Deferred Tax is $30.7 million (2024), against an average of $56.0 million.
- The sharpest annual moves came in 2022 and 2024: Long-Term Deferred Tax sank 69.31% in 2022, then surged 273.33% in 2024.
- Collegium Pharmaceutical's Long-Term Deferred Tax stood at $24.0 million in 2022, then climbed by 9.64% to $26.3 million in 2023, then soared by 273.33% to $98.0 million in 2024, then rose by 14.8% to $112.5 million in 2025, then advanced by 0.91% to $113.6 million in 2026.
- Business Quant data shows COLL's Long-Term Deferred Tax at $113.6 million in Q1 2026, $112.5 million in Q4 2025, and $102.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Collegium Pharmaceutical | 879.69 Mn | 730.37 Mn | 110.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 120.77 Mn |
| Mar 31, 2026 | 113.57 Mn |
| Dec 31, 2025 | 112.54 Mn |
| Sep 30, 2025 | 102.48 Mn |
| Jun 30, 2025 | 91.97 Mn |
| Mar 31, 2025 | 91.67 Mn |
| Dec 31, 2024 | 98.03 Mn |
| Sep 30, 2024 | 72.51 Mn |
| Jun 30, 2024 | 34.18 Mn |
| Mar 31, 2024 | 30.67 Mn |
| Dec 31, 2023 | 26.26 Mn |
| Sep 30, 2023 | 25.74 Mn |
| Jun 30, 2023 | 24.61 Mn |
| Mar 31, 2023 | 23.97 Mn |
| Dec 31, 2022 | 23.95 Mn |
| Sep 30, 2022 | 26.47 Mn |
| Jun 30, 2022 | 28.57 Mn |
| Mar 31, 2022 | 25.55 Mn |
| Dec 31, 2021 | 78.04 Mn |
| Sep 30, 2021 | 63.03 Mn |